Smith & Nephew holding ‘Meet the Management’ event today

Smith & Nephew plc

Smith+Nephew plc (LON:SN, NYSE:SNN), the global medical technology company, will today hold a Meet the Management event for institutional investors and analysts from 12:30pm GMT (7:30am EST), as previously announced.

The event will consist of a formal presentation covering the Group’s innovation strategy and progress of the 12-Point Plan; followed by break-out group meetings with members of the senior leadership team including the Chief Executive Officer, Chief Financial Officer, President of Research & Development, and Presidents of the global business units.

There will be no new information provided on current trading performance or financial targets. 

The formal presentation will be streamed live on the Smith+Nephew corporate website – https://www.smith-nephew.com/en/about-us/investors#events – with a replay available after the event.

Share on:

Latest Company News

Smith & Nephew to host Capital Markets Days in London and New York

Smith & Nephew will hold Capital Markets Days on 8 December in London and 11 December in New York to outline its new strategy, mid-term priorities, and portfolio growth plans.

Smith & Nephew Plc delivers strong H1 with profit up 31%

Smith+Nephew reported 5.0% underlying revenue growth and a 30.6% rise in operating profit for H1 2025. EPS rose 36.6% to 33.5¢ and free cash flow surged to $244m. The company also announced a $500m share buyback for H2, supported by strong cash generation and margin expansion.

Smith & Nephew appoints David King as Non-Executive Director

Smith & Nephew Plc announces the addition of David King as an independent Non-Executive Director, effective July 1, 2025, enhancing their healthcare leadership.

Smith & Nephew Plc 12-Point Plan increasingly delivering better financial performance

Smith & Nephew reports strong financial results for 2024 with significant revenue and profit growth, driven by innovation and strategic restructuring.

Smith & Nephew Plc delivers Q3 revenue of $1,412 million, 4% growth

Smith & Nephew's Q3 2024 update shows a 4% revenue growth to $1,412M. Despite China headwinds, US Orthopaedics and Sports Medicine excelled.

Smith & Nephew Plc transforming into a higher growth and more profitable business

Smith & Nephew plc (LON:SN, NYSE:SNN) reports a robust financial performance for Q2 and H1 2024, showing significant revenue and profit growth.

    Search

    Search